Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis

被引:1
作者
Yurttas, Can [1 ]
Ladurner, Ruth [1 ]
Mihaljevic, Andre L. [1 ]
Strohaeker, Jens [1 ]
机构
[1] Univ Hosp Tubingen, Dept Gen Visceral & Transplant Surg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany
关键词
peritoneal metastasis; regional cancer therapy; soft tissue sarcoma; PROGNOSTIC-FACTOR; VOLUME; HIPEC;
D O I
10.3390/cancers16173034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Surgery to remove all peritoneal metastases from soft tissue sarcoma combined with heated intraperitoneal chemotherapy has been suggested; however, robust evidence is lacking due to the small number of cases. Therefore, we retrospectively analyzed the results of 10 patients who underwent surgery with heated intraabdominal chemotherapy at our department between 2017 and 2024. Complete removal of all tumor lesions was possible in most of the patients with acceptable rates of postoperative complications. We were therefore able to demonstrate the safety and feasibility of surgery with heated intraabdominal chemotherapy in this subset of patients.Abstract (1) Background: Cytoreductive surgery (CRS) with HIPEC is considered the standard of care for selected patients with peritoneal carcinomatosis, but evidence-based treatment recommendations for the therapy of peritoneal sarcomatosis are scarce. (2) Methods: We retrospectively analyzed all adult patients treated with CRS and HIPEC for peritoneal sarcomatosis between 2017 and 2024. (3) Results: Ten patients with a median age of 46.1 years (range: 23-77 years) with metachronous (40%) or synchronous (60%) peritoneal sarcomatosis from six different tumor entities were treated according to tumor board recommendation using CRS and HIPEC with cisplatin and doxorubicin over 60 min at 42.0 degrees C. The length of stay in the intensive care unit and hospital was 1.24 (0.6-1.9 days) and 11.1 days (6-17 days), respectively. Complete cytoreduction was achieved in 90% of the patients, with a median PSI of 11.5. Postoperative complications occurred in five cases, but no surgical revisions were necessary, and no acute kidney damage was recorded. (4) Conclusions: CRS with HIPEC in the presence of peritoneal sarcomatosis could be safely performed in our collective. Whether this resulted in an oncological treatment benefit cannot be concluded in view of the heterogeneous and small collective. Therefore, larger and prospective studies are warranted.
引用
收藏
页数:10
相关论文
共 33 条
[1]   Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Management of Peritoneal Sarcomatosis: A Preliminary Single-Center Experience from Saudi Arabia [J].
Abu-Zaid, Ahmed ;
Azzam, Ayman ;
Abuzaid, Mohammed ;
Elhassan, Tusneem ;
Albadawi, Naryman ;
Alkhatib, Lynn ;
AlOmar, Osama ;
Alsuhaibani, Abdullah ;
Amin, Tarek ;
Al-Badawi, Ismail A. .
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
[2]   Cytoreductive Surgery with Bidirectional Intraoperative Chemotherapy (BDIC) Using Intravenous Ifosfamide Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Sarcomatosis: A Retrospective Cohort Study [J].
Almasri, Mohammed S. ;
Hakeam, Hakeam A. ;
Alnajashi, Norah S. ;
Alzamil, Lana A. ;
Azzam, Ayman Z. ;
Amin, Tarek M. .
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) :2368-2377
[3]   Multifocality in Retroperitoneal Sarcoma A Prognostic Factor Critical to Surgical Decision-Making [J].
Anaja, Daniel A. ;
Lahat, Guy ;
Liu, Jun ;
Xing, Yan ;
Cormier, Janice N. ;
Pisters, Peter W. ;
Lev, Dina C. ;
Pollock, Raphael E. .
ANNALS OF SURGERY, 2009, 249 (01) :137-142
[4]   Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer A Phase 3 Randomized Clinical Trial [J].
Arjona-Sanchez, Alvaro ;
Espinosa-Redondo, Esther ;
Gutierrez-Calvo, Alberto ;
Segura-Sampedro, Juan J. ;
Perez-Viejo, Estibalitz ;
Concepcion-Martin, Vanessa ;
Sanchez-Garcia, Susana ;
Garcia-Fadrique, Alfonso ;
Prieto-Nieto, Isabel ;
Barrios-Sanchez, Pedro ;
Torres-Melero, Juan ;
Ramirez Faraco, Maria ;
Prada-Villaverde, Arancha ;
Carrasco-Campos, Joaquin ;
Artiles-Armas, Manuel ;
Villarejo-Campos, Pedro ;
Ortega-Perez, Gloria ;
Boldo-Roda, Emrique ;
Sanchez-Hidalgo, Juan-Manuel ;
Casado-Adam, Angela ;
Rodriguez-Ortiz, Lidia ;
Aranda, Enrique ;
Cano-Osuna, Maria Teresa ;
Diaz-Lopez, Cesar ;
Romero-Ruiz, Antonio ;
Briceno-Delgado, Javier ;
Rufian-Pena, Sebastian .
JAMA SURGERY, 2023, 158 (07) :683-691
[5]   Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial [J].
Aronson, S. Lot ;
Lopez-Yurda, Marta ;
Koole, Simone N. ;
Leeuwen, Jules H. Schagen van ;
Schreuder, Hendrik W. R. ;
Hermans, Ralph H. M. ;
Hingh, Ignace H. J. T. de ;
Gent, Mignon D. J. M. van ;
Arts, Henriette J. G. ;
Ham, Maaike A. P. C. van ;
Dam, Peter A. van ;
Vuylsteke, Peter ;
Aalbers, Arend G. J. ;
Verwaal, Victor J. ;
Vijver, Koen K. Van de ;
Aaronson, Neil K. ;
Sonke, Gabe S. ;
van Driel, Willemien .
LANCET ONCOLOGY, 2023, 24 (10) :1109-1118
[6]   Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? [J].
Baratti, Dario ;
Pennacchioli, Elisabetta ;
Kusamura, Shigeki ;
Fiore, Marco ;
Balestra, Maria Rosaria ;
Colombo, Chiara ;
Mingrone, Elvira ;
Alessanrdro, Gronchi ;
Deraco, Marcello .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (12) :3220-3228
[7]  
Bilimoria MM, 2002, CANCER, V94, P2441, DOI 10.1002/cncr.10504
[8]   Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis [J].
Bonvalot, S ;
Cavalcanti, A ;
Le Péchoux, C ;
Terrier, P ;
Vanel, D ;
Blay, JY ;
Le Cesne, A ;
Elias, D .
EJSO, 2005, 31 (08) :917-923
[9]  
Bryan ML, 2014, AM SURGEON, V80, P890
[10]   Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma [J].
Diaz-Montes, Teresa P. ;
El-Sharkawy, Farah ;
Lynam, Sarah ;
Harper, Amy ;
Sittig, Michelle ;
MacDonald, Ryan ;
Gushchin, Vadim ;
Sardi, Armando .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (06) :1130-1137